Home › NCT07634640
Hearts on Fire: Targeting Inflammation in Heart Failure With Preserved Ejection Fraction
RecruitingEarly phase 1
Omega-3 Fatty Acids and Myocardial Inflammation in HFpEF: Preliminary Data and Next Steps
Who can join
Ages 18 to 85 · All sexes
Full eligibility criteria
Inclusion Criteria: * HFpEF Exclusion Criteria: * Renal insufficiency
About the study
Subjects undergo a gadolinium-based CMR followed by an iron infusion and then a repeat CMR in 72 hours
What is being tested
- Ferumoxytol infusion (drug)
Sponsor: University of Florida · Participants: 70 · Started: Nov 3, 2023
Contact the study team
- Ellen C Keeley, MD, MS · Phone: 800-265-0820
- Vanessa H Scheuble · Phone: 800-555-0820
Official record on ClinicalTrials.gov — NCT07634640
Locations in the U.S.
| Florida | University of Florida, Gainesville |
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.